Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

Comparison of Rivaroxaban and Low Molecular Weight Heparin in the Treatment of Cancer-Associated Venous Thromboembolism

Craig I. Coleman, Kimberly Snow Caroti, Khaled Abdelgawwad, George Psaroudakis, Marcela Rivera, Gunnar Brobert, Alexander T. Cohen, Alok A. Khorana, Cecilia Becattini, Agnes Y. Lee, Anders Ekbom, Marc Carrier

Blood (2022) 140 (Supplement 1): 11368–11369.

https://doi.org/10.1182/blood-2022-166949

Published: 2022

Journal Articles

Rivaroxaban Versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism: A Head-to-Head Analysis of the United States Cohort of the Observational Study in Cancer-Associated Thrombosis for Rivaroxaban: (H2H-OSCAR-US)

Kimberly Snow Caroti, Khaled Abdelgawwad, George Psaroudakis, Marcela Rivera, Gunnar Brobert, Alexander T Cohen, Alok A Khorana, Cecilia Becattini, Agnes Y. Lee, Anders Ekbom, Marc Carrier, Craig I. Coleman

Blood (2022) 140 (Supplement 1): 1257–1258.

https://doi.org/10.1182/blood-2022-167801

Published: 2022

Journal Articles

Patient Characteristics and Temporal Changes in Anticoagulation Treatment Patterns in Patients Diagnosed with Cancer-Associated Thrombosis: An Oscar-US Analysis

Craig I. Coleman, Kimberly Snow Caroti, Khaled Abdelgawwad, George Psaroudakis, Samuel Fatoba, Marcela Rivera, Gunnar Brobert, Christopher Brescia

Blood (2021) 138 (Supplement 1): 2132.

https://doi.org/10.1182/blood-2021-151566

Published: 2021